| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RRX | Common Stock | Options Exercise | $4.34M | +55.6K | +54.06% | $78.05 | 158K | Nov 7, 2024 | Direct | F1, F2 |
| transaction | RRX | Common Stock | Sale | -$1.58M | -8.77K | -5.54% | $180.03 | 150K | Nov 7, 2024 | Direct | F1, F2, F3 |
| transaction | RRX | Common Stock | Tax liability | -$6.8M | -38K | -25.42% | $178.92 | 112K | Nov 7, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RRX | Stock Appreciation Rights | Options Exercise | $0 | -55.6K | -100% | $0.00 | 0 | Nov 7, 2024 | Common Stock | 55.6K | $78.05 | Direct | F1, F4 |
| holding | RRX | Stock Appreciation Rights | 47.5K | Nov 7, 2024 | Common Stock | 47.5K | $84.39 | Direct | F5 | |||||
| holding | RRX | Stock Appreciation Rights | 33.4K | Nov 7, 2024 | Common Stock | 33.4K | $133.77 | Direct | F5 | |||||
| holding | RRX | Stock Appreciation Rights | 32.7K | Nov 7, 2024 | Common Stock | 32.7K | $151.27 | Direct | F5 | |||||
| holding | RRX | Stock Appreciation Rights | 30.3K | Nov 7, 2024 | Common Stock | 30.3K | $154.20 | Direct | F5 | |||||
| holding | RRX | Stock Appreciation Rights | 28.6K | Nov 7, 2024 | Common Stock | 28.6K | $168.47 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Exercise of Stock Appreciation Rights ("SARs") expiring on May 8, 2029. Of the 17,549 underlying shares that the reporting person received net of shares withheld to cover the SARs' exercise price and applicable taxes, 8,775 shares were retained and the remaining 8,774 shares were sold as indicated in this Form 4 for tax and estate planning purposes. |
| F2 | Amount beneficially owned reflects deduction of 263.228 dividend equivalent shares ("DSUs") associated with unearned performance share units that were inadvertently credited to the reporting person in previous Form 4 reports. These DSUs will be credited to the reporting person's beneficial ownership total when, if and as earned. |
| F3 | The price in Column 4 is a weighted average price. The prices actually received ranged from $180.00 to $180.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| F4 | Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant. |
| F5 | Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant. |
| F6 | Granted as stock-settled SARs under the 2023 Omnibus Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant. |